Substance or device – a distinction without a difference?
In the wake of the UK Supreme Court decision in Warner-Lambert v Actavis (post here), second medical use claims have received considerable attention from the IP commentariat. We take a look at yet another controversy associated with the claim form: the nature of the “medical products” to which they can be applied. Second medical use claims […]